Xspray Pharma AB (publ) (STO:XSPRAY)
10.18
-0.30 (-2.86%)
Nov 20, 2026, 5:29 PM CET
Xspray Pharma AB Revenue
Xspray Pharma AB had revenue of 1.48M SEK in the quarter ending September 30, 2026, a decrease of -41.15%. This brings the company's total for the last twelve months to 11.15M, up 88.73% year-over-year. In the year 2025, Xspray Pharma AB had annual revenue of 6.43M with 206.87% growth. That makes Xspray Pharma AB the 44,144th largest company in the world by revenue and 692nd in Sweden.
Revenue (ttm)
11.15M
Revenue Growth
+88.73%
P/S Ratio
67.15
Revenue / Employee
299.50K
Employees
24
Market Cap
482.70M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.43M | 4.34M | 206.87% |
| Dec 31, 2024 | 2.10M | -29.67M | -93.40% |
| Dec 31, 2023 | 31.77M | 29.59M | 1,357.20% |
| Dec 31, 2022 | 2.18M | 1.52M | 232.32% |
| Dec 31, 2021 | 656.00K | -708.00K | -51.91% |
| Dec 31, 2020 | 1.36M | 990.00K | 264.71% |
| Dec 31, 2019 | 374.00K | 11.00K | 3.03% |
| Dec 31, 2018 | 363.00K | -22.66M | -98.42% |
| Dec 31, 2017 | 23.02M | 1.83M | 8.62% |
| Dec 31, 2016 | 21.19M | 16.57M | 358.36% |
| Dec 31, 2015 | 4.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.31M |
| Sprint Bioscience AB | 134.13M |
| Oncopeptides AB | 103.50M |
| Intervacc AB | 17.35M |
| Corline Biomedical AB | 13.44M |
| Medivir AB | 8.51M |
| FluoGuide | 404.33K |
| Infant Bacterial Therapeutics AB | -1.00K |
Xspray Pharma AB News
- 16 days ago - Xspray Pharma AB Quarterly report: Q3 2026 - Filings
- 17 days ago - Xspray Pharma AB Transcript: BioStock Life Science Summit 2026 - Transcripts
- 3 months ago - Xspray Pharma AB Transcript: FDA announcement - Transcripts
- 3 months ago - Xspray Pharma AB Press release: FDA announcement - Filings
- 3 months ago - Xspray Pharma AB Quarterly report: Q2 2026 - Filings
- 6 months ago - Xspray Pharma AB Quarterly report: Q1 2026 - Filings
- 9 months ago - Xspray Pharma AB Annual report: Q4 2025 - Filings
- 9 months ago - Xspray Pharma AB Quarterly report: Q4 2025 - Filings